Practice parameter: Evaluation of the child with global developmental delay - Report of the quality standards subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurology Society

被引:533
作者
Shevell, M
Ashwal, S
Donley, D
Flint, J
Gingold, M
Hirtz, D
Majnemer, A
Noetzel, M
Sheth, RD
机构
[1] Loma Linda Univ, Sch Med, Dept Pediat, Loma Linda, CA 92350 USA
[2] McGill Univ, Dept Neurol Neurosurg, Montreal, PQ H3A 2T5, Canada
[3] McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada
[4] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ H3A 2T5, Canada
[5] Montreal Childrens Hosp, Div Pediat Neurol, Montreal, PQ H3H 1P3, Canada
[6] Univ Oxford, Div Psychiat, Wellcome Trust Ctr Human Genet, Oxford OX1 2JD, England
[7] NINDS, NIH, Bethesda, MD 20892 USA
[8] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA
[9] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA
[10] Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA
[11] Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA
关键词
D O I
10.1212/01.WNL.0000031431.81555.16
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To make evidence-based recommendations concerning the evaluation of the child with a nonprogressive global developmental delay. Methods: Relevant literature was reviewed, abstracted, and classified. Recommendations were based on a four-tiered scheme of evidence classification. Results: Global developmental delay is common and affects 1% to 3% of children. Given yields of about 1%, routine metabolic screening is not indicated in the initial evaluation of a child with global developmental delay. Because of the higher yield (3.5% to 10%), even in the absence of dysmorphic features or features suggestive of a specific syndrome, routine cytogenetic studies and molecular testing for the fragile X mutation are recommended. The diagnosis of Rett syndrome should be considered in girls with unexplained moderate to severe developmental delay. Additional genetic studies (e.g., subtelomeric chromosomal rearrangements) may also be considered in selected children. Evaluation of serum lead levels should be restricted to those children with identifiable risk factors for excessive lead exposure. Thyroid studies need not be undertaken (unless clinically indicated) if the child underwent newborn screening. An EEG is not recommended as part of the initial evaluation unless there are historical features suggestive of epilepsy or a specific epileptic syndrome. Routine neuroimaging, with MRI preferred to CT, is recommended particularly if abnormalities are found on physical examination. Because of the increased incidence of visual and auditory impairments, children with global developmental delay may undergo appropriate visual and audiometric assessment at the time of diagnosis. Conclusions: A specific etiology can be determined in the majority of children with global developmental delay. Certain routine screening tests are indicated and depending on history and examination findings, additional specific testing may be performed.
引用
收藏
页码:367 / 380
页数:14
相关论文
共 124 条
[1]   Screening for congenital hypothyroidism in cognitively delayed children [J].
Al-Qudah, AA .
ANNALS OF TROPICAL PAEDIATRICS, 1998, 18 (04) :285-288
[2]  
*AM AC OPHTH, 1997, PED EYE EV
[3]  
AM. PSYCHIATRIC ASS'N, 2000, DIAGN STAT MAN MENT, P41
[4]   Subtelomeric rearrangements detected in patients with idiopathic mental retardation [J].
Anderlid, BM ;
Schoumans, J ;
Annerén, G ;
Sahlén, S ;
Kyllerman, M ;
Vujic, M ;
Hagberg, B ;
Blennow, E ;
Nordenskjöld, M .
AMERICAN JOURNAL OF MEDICAL GENETICS, 2002, 107 (04) :275-284
[5]   PRETEACHING DEVELOPMENTALLY DELAYED PRESCHOOLERS TO AID VISION SCREENING [J].
BACHMAN, JA ;
BACHMAN, WG ;
FRANZEL, AS ;
MARCUS, MC .
OPTOMETRY AND VISION SCIENCE, 1994, 71 (11) :713-716
[6]   Study of 250 children with idiopathic mental retardation reveals nine cryptic and diverse subtelomeric chromosome anomalies [J].
Baker, E ;
Hinton, L ;
Callen, DF ;
Altree, M ;
Dobbie, A ;
Eyre, HJ ;
Sutherland, GR ;
Thompson, E ;
Thompson, P ;
Woollatt, E ;
Haan, E .
AMERICAN JOURNAL OF MEDICAL GENETICS, 2002, 107 (04) :285-293
[7]  
BATSHAW ML, 1997, CHILDREN DISABILITIE, P335
[8]  
Battaglia A, 1999, AM J MED GENET, V82, P60, DOI 10.1002/(SICI)1096-8628(19990101)82:1<60::AID-AJMG12>3.3.CO
[9]  
2-W
[10]  
BELLINGER DC, 1992, PEDIATRICS, V90, P855